Lilly’s amassing of a $1.5bn pre-launch inventory follows sizeable investments into US manufacturing facilities.

The FDA has approved a new four-dose, single-patient-use KwikPen for Zepbound (tirzepatide), giving patients a full month of treatment in one device.

Milestone achieved in Scribe and Lilly’s ongoing collaboration to develop in vivo CRISPR-based therapeutics for neurological and neuromuscular diseasesAchievement validates Scribe’s technologies and ...

Lilly Larson could have quit gymnastics a long time ago. It would be understandable — she lives an hour away from the nearest gym. "Jamestown is an hour from where I live, but it was the only option ...

Novo Nordisk will set a $675/month US list price (effective January 1, 2027) for Wegovy, Ozempic, and Rybelsus, targeting affordability for high-deductible and coinsurance designs. Impacted doses ...

Moderator and TBJ reporter Lilly Egan (left to right), and Mentoring Monday 2026 panelists Jennifer Borrero, Dean of Students at Salem College, Emily Edwards, Chief Digital & Marketing Officer for ...

The AI in Life Science Market is anticipated to experience a remarkable compound annual growth rate (CAGR) of around 25% in the coming years, highlighting the increasing reliance on AI technologies ...

Labor force participation for women with small children continues to float above prepandemic levels, thanks to flexible work setups — and rising costs.

International Equities added another 5% in the fourth quarter, finishing up over 30% for the year, the largest gain since ...

Taiwan’s PharmaEssentia has committed $46 million to build a Puerto Rico drug manufacturing facility to serve the U.S. market ...

Never say never. There's certainly a mathematical path to that level, if the company navigates it correctly.

Some deep-sea fish may be able to see light in a different way from most other vertebrates, according to a new study. The ...